Effects of Two Estroprogestins Containing Ethinylestradiol 30 μg and Drospirenone 3 mg and Ethinylestradiol 30 μg and Chlormadinone 2 mg on Skin and Hormonal Hyperandrogenic Manifestations

    January 2008 in “ Gynecological endocrinology ”
    Stefano Lello, Grazia Primavera, Laura Colonna … Desanka Raskovic
    Studysummary In this study, two different estroprogestin treatments significantly improved skin conditions and decreased androgen levels in hyperandrogenic women, with EE/DRSP showing more pronounced hormonal changes and skin improvements compared to EE/CMA.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Dermatologic Manifestations of Polycystic Ovary Syndrome American Journal of Clinical Dermatology · 2007
    2. Androgens and Antiandrogens: Impact on Women's Health and Hormone Replacement Therapy Annals of the New York Academy of Sciences · 2003
    3. Progestogens With Antiandrogenic Properties Drugs · 2003

    Related research 1

    1. Features of Hyperandrogenism in Men Problemy e̊ndokrinologii · 2021